In relation to liver disease, previous studies have revealed that genistein inhibits EGFR system and has a protective effect during the processes of acute and chronic liver disease (Rodriguez et al. 2016; Tanjak et al. 2018; Xin et al. 2019; Semeniuk et al. 2021). This evidence concerns the gene EGFR and liver disorder.